PhD Andrej Preželj

PhD Andrej Preželj
no.: 20246 source: ARIS

researcher – active in research organisation
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • Croatian
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • German
  • Reading: Functional
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
1.05.00  Natural sciences and mathematics  Biochemistry and molecular biology   
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Pharmaceutical chemistry, organic synthesis, structural biology
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
0
A''
0
A'
0
A1/2
0
CI10
139
CImax
39
h10
6
A1
0
A3
0
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 17  311  283  16.65 
Scopus 19  357  327  17.21 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Lek Pharmaceutical Company d.d.  Raziskovalna skupina Lek (Slovene) 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. Z1-7572  Preclinical development of a novel inhibitor of class A and class C beta-lactamases   9/1/2005 - 8/31/2007  PhD Tomaž Šolmajer   406 
2. L1-6707  Design, synthesis and test of potencial hypolipidemic drugs with a new target   2/1/2004 - 1/30/2007  PhD Uroš Urleb   3,581 
3. L3-5084  Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)   1/1/2003 - 12/31/2005  PhD Mojca Stegnar   5,775 
4. L1-5292  Razvoj novih inhibitorjev beta laktamaz razreda A in C (NOVACLIN) (Slovene)   1/1/2003 - 12/31/2005  PhD Tomaž Šolmajer   642 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0340  Načrtovanje in predklinični razvoj novih zdravilnih učinkovin (Slovene)   7/1/2006 - 12/31/2008 PhD Uroš Urleb   1,608 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2004 - 12/31/2008 PhD Danijel Kikelj   6,446 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite